Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

978 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.
Tahara N, Yamagishi S, Takeuchi M, Honda A, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Matsui T, Imaizumi T. Tahara N, et al. Among authors: honda a. Diabetes Care. 2012 Dec;35(12):2618-25. doi: 10.2337/dc12-0087. Epub 2012 Aug 21. Diabetes Care. 2012. PMID: 22912424 Free PMC article.
Molecular imaging of vascular inflammation.
Tahara N, Tahara A, Honda A, Nitta Y, Kodama N, Yamagishi S, Imaizumi T. Tahara N, et al. Among authors: honda a. Curr Pharm Des. 2014;20(14):2439-47. doi: 10.2174/13816128113199990479. Curr Pharm Des. 2014. PMID: 23844819 Review.
Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
Kodama N, Tahara N, Tahara A, Honda A, Nitta Y, Mizoguchi M, Kaida H, Ishibashi M, Abe T, Ikeda H, Narula J, Fukumoto Y, Yamagishi S, Imaizumi T. Kodama N, et al. Among authors: honda a. J Clin Endocrinol Metab. 2013 Nov;98(11):4438-45. doi: 10.1210/jc.2013-2920. Epub 2013 Sep 12. J Clin Endocrinol Metab. 2013. PMID: 24030946 Clinical Trial.
Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Ikeda H, Yamagishi S, Imaizumi T. Nitta Y, et al. Among authors: honda a. JACC Cardiovasc Imaging. 2013 Nov;6(11):1172-82. doi: 10.1016/j.jcmg.2013.09.004. JACC Cardiovasc Imaging. 2013. PMID: 24229770 Free article. Clinical Trial.
978 results